Meet Our Team
Proven Pharmaceutical and Ophthalmic Execution
Leadership Team
Mr. Doshi has over 40 years of experience working at major contact lens companies including Pilkington Barnes Hind, Wesley Jessen, and Bausch+Lomb. His creative vision and innovative approach to solving the problems faced by contact lens manufacturers, eye care professionals, and contact lens users has resulted in 40+ patents. He is recognized as a leader in the field of drug delivery from contact lenses, for his entrepreneurial spirit, and for his passion for helping to protect sight.
Mr. Fancher is leading business development efforts for MediPrint™ Ophthalmics. Before working with MediPrint™ Ophthalmics Mr. Fancher was the Senior VP of Sales for Coopervision, helping them grow from $14M to $450M in sales. Prior to that position, he worked for Allergan and Johnson and Johnson. He also was the VP of Sales and VP of Business Development at Synergeyes.
Michael Nash has 40 years of experience working with venture-backed pharmaceutical, molecular diagnostic and device start-up companies. During his career, Mr. Nash held positions in finance, marketing, sales and R&D. Executive management positions include Executive Vice President, General Manager, President and CEO.
Mr. Nash raised more than $160M in venture capital and negotiated licensing and distribution agreements with numerous large US healthcare companies, including J&J, Allergan and Bausch and Lomb.
Board of Directors
Mr. Doshi has over 40 years of experience working at major contact lens companies including Pilkington Barnes Hind, Wesley Jessen, and Bausch+Lomb. His creative vision and innovative approach to solving the problems faced by contact lens manufacturers, eye care professionals, and contact lens users has resulted in 40+ patents. He is recognized as a leader in the field of drug delivery from contact lenses, for his entrepreneurial spirit, and for his passion for helping to protect sight.
Dr. Kokila Doshi is a professor of economics in the University of San Diego School of Business, which she joined in 1988. She developed two new international courses in the area of Asia-Pacific Business and Development and another course in Tourism and Travel Economics. Her interest in applied economics and regional development is reflected in her economic impact studies. Her research interests focus on the privatization of public enterprises saving rates and economic policies of the Asian-Pacific countries. Dr. Doshi was a co-founder of the company, has been an active executive with MediPrint Ophthalmics since its inception, and serves on its board.
Dr. Hemmati is a board-certified ophthalmologist and Harvard-trained cornea specialist and has been Adjunct Assistant Clinical Professor of Ophthalmology at USC Keck School of Medicine and Attending Physician at LA County USC Medical Center. He also previously served as Director, Clinical Development at Allergan in the Ophthalmology Therapeutic Area, as Clinical Scientist on several Phase 1, 2, and 3 studies. In his scientific career, he invented a hydrogel for sustained-release topical drug delivery to the eye with Dr. Robert Langer at MIT.
Scientific Advisory Board
Dr. Okeke is an Ivy League-trained, board-certified ophthalmologist specializing in glaucoma and cataract surgery. She serves as the lead glaucoma specialist at Virginia Eye Consultants, and is also an Assistant Professor of Ophthalmology at the Eastern Virginia Medical School in Norfolk, VA. She has two decades of glaucoma experience ranging from cutting edge research, mastering micro-invasive surgical techniques, to training other doctors, speaking, and writing about her techniques and innovative ideas. In 2021, she was voted to The Ophthalmologist’s Top 100 Power List of Most Influential Female Figures in Ophthalmology internationally.
Dr. Hemmati is a board-certified ophthalmologist and Harvard-trained cornea specialist and has been Adjunct Assistant Clinical Professor of Ophthalmology at USC Keck School of Medicine and Attending Physician at LA County USC Medical Center. He also previously served as Director, Clinical Development at Allergan in the Ophthalmology Therapeutic Area, as Clinical Scientist on several Phase 1, 2, and 3 studies. In his scientific career, he invented a hydrogel for sustained-release topical drug delivery to the eye with Dr. Robert Langer at MIT.
Dr. Gaddie, in 2015, was selected as one of the Most Influential in Optometry by Optometric Management, named a “Leader in Sight” by Bausch & Lomb, and was awarded the Kentucky Optometric Association Optometrist of The Year Award. Currently, he is the director of Gaddie Eye Centers, a multi-location full-service practice in Louisville. He Co-Founded Keplr Vision, a Private Equity backed consolidation company in eyecare with over 170 locations in 29 states, where he serves as Chief Medical Officer. Dr. Gaddie is a Fellow of the American Academy of Optometry and Executive Vice President of the Optometric Glaucoma Society (OGS).
Dr. Dunbar graduated from the Michigan College of Optometry at Ferris State University in 1986 and went on to complete a Fellowship in Ocular Disease at the Omni Eye Services of Lexington, Kentucky. He has been on staff at the University of Miami’s Bascom Palmer Eye Institute for over 30 years and currently serves as Director of Optometric Services. Dr. Dunbar is a Fellow of the American Academy of Optometry and a founding member of the Optometric Glaucoma Society and the Optometric Retina Society. He also serves on the Editorial Board for Review of Optometry.
Dr. Davis is the medical director at the Contact Lens Clinic at Davis EyeCare. He is also co-founder of EyeVis, Eye and Vision Research Institute developing novel contact lens designs as well as forging the knowledge of anterior segment pathophysiology. Dr. Davis has been recognized as a Diplomate in the Corneal, Contact Lens and Refractive Technology section of the American Academy of Optometry as well as an inductee in National Academy Practice in Optometry.
Dr. Giaconi is faculty in the Glaucoma Division at the Stein Eye Institute, David Geffen School of Medicine, UCLA, where she actively practices and operates on patients with glaucoma and cataracts. She holds the title of Health Sciences Professor of Ophthalmology. She also serves as Chief of Ophthalmology for the Greater Los Angeles Veterans Administration—a major teaching site for residents and fellows of the Stein Eye Institute and medical students from the David Geffen School of Medicine and Charles Drew School of Medicine. Dr. Giaconi has published over 40 research papers with colleagues in the areas of glaucoma and in medical education.
Dr. Whitley is the Director of Referral Services at Virginia Eye Consultants in Norfolk, VA. He received his optometry degree from Pacific University College of Optometry, completed an optometric residency at Eye Care Associates of Nevada, and received his MBA from University of Nevada, Reno. Currently, Dr. Whitley serves as the Chair of the American Academy of Optometry Anterior Segment Section, co-chief medical editor of Collaborative Eye, and Contributing Editor for the Review of Optometry. Over the past decade, Dr. Whitley has been involved in over two dozen clinical trials in pharmaceutical development and ophthalmic devices. In 2020, he was voted the Optometrist of the Year by the Virginia Optometric Association.